BridgeBio Pharma, Inc. - Insider Non-Derivative Transactions at BridgeBio Oncology Therapeutics, Inc. (BBOT) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Oct 10, 2025, BridgeBio Pharma, Inc.'s relationship to BridgeBio Oncology Therapeutics, Inc. (BBOT) is TenPercentOwner, and currently has 14,589,846 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BBOT insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

BridgeBio Pharma, Inc. - Insider Non-Derivative Transactions of BBOT Common Stock

BridgeBio Pharma, Inc. - Insider Non-Derivative Transactions at BBOT

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 11, 2025	J -- (Common Stock)	784720	0	14589846